Clinical Drug Experience Knowledgebase

dimethyl fumarate (tecfidera) (1 trial)

etomidate (amidate) (1 trial)

propofol (diprivan) (1 trial)

somatropin (protropin) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

tetrandrine (1 trial)

thrombopoietin (1 trial)

cyclophosphamide (cytoxan) (2 trials)

doxorubicin (Doxil) (2 trials)

ferric citrate (AURYXIA) (1 trial)

lenalidomide (revlimid) (2 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

polyethylene glycol (1 trial)

potassium sulfate (1 trial)

prednisone (meticorten) (2 trials)

rituximab (rituxan) (1 trial)

sevelamer (renagel) (1 trial)

sodium sulfate (1 trial)

vincristine (oncovin) (2 trials)

zanubrutinib (Brukinsa) (1 trial)

ak105 (1 trial)

bat4406f (1 trial)

camrelizumab (2 trials)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (2 trials)

docetaxel (taxotere) (1 trial)

durvalumab (imfinzi) (1 trial)

etoposide (vepesid) (1 trial)

fruquintinib (Fruzaqla) (1 trial)

gimeracil (1 trial)

hs-10374 (1 trial)

lapatinib (tykerb) (1 trial)

ofatumumab (arzerra) (1 trial)

oteracil (1 trial)

rc48-adc (1 trial)

tegafur (1 trial)

toripalimab (LOQTORZ) (1 trial)

esketamine (spravato) (1 trial)

ft-002 (1 trial)

hs-10241 (1 trial)

anlotinib (1 trial)

beclomethasone (vanceril) (1 trial)

dexmedetomidine (precedex) (1 trial)

formoterol (foradil) (1 trial)

gabapentin (neurontin) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

midodrine (proamatine) (1 trial)

pregabalin (lyrica) (1 trial)

sintilimab (1 trial)

sodium bicarbonate (1 trial)